Showing results (31-40 of 190) with videos related to
Sort By:
Pageof 19
Drugs|August 26, 2017
Drugs in Clinical Development for Fungal InfectionsMaria F Gonzalez-Lara, Jose Sifuentes-Osornio, Luis Ostrosky-ZeichnerAntimicrobial Agents and Chemotherapy|September 6, 2007
Effects of serum on in vitro susceptibility testing of echinocandinsZekaver Odabasi, Victor Paetznick, John H Rex, et al.Open Forum Infectious Diseases|August 4, 2023
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data AnalysisMohanad M Al-Obaidi, Luis Ostrosky-Zeichner, David E NixThe Journal of Antimicrobial Chemotherapy|May 1, 2024
Community-acquired pneumonia: a US perspective on the guideline gapMaricar Malinis, Lilian Abbo, Jose A Vazquez, et al.Expert Opinion on Pharmacotherapy|December 1, 2005
Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directionsMelissa D Johnson, Michael Kleinberg, Larry Danziger, et al.Open Forum Infectious Diseases|May 10, 2018
Outpatient Infection Prevention: A Practical PrimerFozia Steinkuller, Kristofer Harris, Karen J Vigil, et al.Current Opinion in Infectious Diseases|September 11, 2024
Update on diagnosis and treatment of fungal meningitis: lessons from recent outbreaksPaula Beltran-Reyes, Luis Ostrosky-Zeichner, Maria F Gonzalez-LaraInfectious Disease Clinics of North America|January 7, 2003
Deeply invasive candidiasisLuis Ostrosky-Zeichner, John H Rex, John Bennett, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasisSiraya Jaijakul, Jose A Vazquez, Robert N Swanson, et al.American Journal of Infection Control|November 30, 2024
Evaluation of Certification Board of Infection Control and Epidemiology, Inc Certification in Infection Control (CIC) examination ratesKayla E Ruch, Anabel Rodriguez, Luis Ostrosky-Zeichner, et al.Pageof 19